Mannkind (MNKD) Gross Profit Growth (5y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 44.50% |
| Dec 31, 2025 | 45.97% |
| Sep 30, 2025 | 45.85% |
| Jun 30, 2025 | 86.70% |
| Mar 31, 2025 | 43.94% |
| Dec 31, 2024 | 44.66% |
| Sep 30, 2024 | 65.60% |
| Jun 30, 2024 | 78.62% |
| Mar 31, 2024 | 35.99% |
| Dec 31, 2023 | 47.97% |
| Sep 30, 2023 | 116.29% |
| Jun 30, 2023 | 98.47% |
| Mar 31, 2023 | 120.65% |
| Dec 31, 2022 | 164.49% |
| Sep 30, 2022 | 57.25% |
| Jun 30, 2022 | -8.11% |
| Mar 31, 2022 | -29.17% |
| Dec 31, 2021 | -35.09% |
| Sep 30, 2021 | -34.95% |
| Jun 30, 2021 | 46.14% |
| Mar 31, 2021 | 35.33% |
| Dec 31, 2020 | 18.14% |
| Sep 30, 2020 | 90.66% |
| Jun 30, 2020 | 9.38% |
| Mar 31, 2020 | 53.11% |